NEW YORK (GenomeWeb) – Dutch software company Genalice said this week that it has signed a product development partnership with Intel.
Under the terms of the agreement, Intel will be the main hardware supplier for Genalice. The partners will also work on optimizing the Genalice Map software to run on Intel Xeon Processors, the company said. Based on data from internal benchmarks, Genalice's software currently takes 24 hours each to map short reads from 42 human genomes and 42 tomato genomes when it's run on an Intel Xeon ES server. Moving forward, both companies will work on improving on these early results, according to Jos Lunenberg, Genalice's chief business officer.
Last week, Genalice announced that it had received a multimillion dollar capital investment from Redbrae, a consortium of US and UK-based private equity investors, to support product development and distribution. The company has not disclosed the exact amount of the investment.